Isolator Decontamination cycle verification in Pharmaceutical microbiology : Step-by-Step Guide
Isolator Decontamination Cycle Verification
Isolator decontamination cycle verification is an essential process in pharmaceutical microbiology to ensure sterile operations and compliance with regulatory standards such as FDA, EU GMP, and WHO guidelines. This process verifies that sterilization is effective and reproducible before aseptic manufacturing.
Purpose
The purpose of isolator decontamination cycle verification is to confirm that the decontamination process effectively eliminates microbial contamination, ensuring product safety and regulatory compliance.
Types of Isolator Decontamination
- Full-cycle decontamination: Performed after isolator installation or before a new batch.
- Routine decontamination: Performed daily or between production shifts.
Objectives of Cycle Verification
- Confirm sterilant reaches all internal surfaces of the isolator.
- Verify contact time, concentration, and temperature.
- Ensure reproducibility across multiple cycles.
- Confirm kill of biological indicators (BIs) used for validation.
Step-by-Step Process
Step 1: Preparation
- Ensure the isolator is empty and operational.
- Check all sensors, alarms, and door interlocks.
- Place biological indicators (BIs) at critical locations.
- Place chemical indicators (CIs) at multiple positions.
Step 2: Running the Decontamination Cycle
- Initiate the automated decontamination cycle (VHP or other sterilant).
- Monitor parameters: sterilant concentration, exposure time, temperature, and humidity.
Step 3: Monitoring
- Use data loggers or isolator monitoring system to record parameters.
- Confirm alarms and interlocks function correctly.
Step 4: Post-Cycle Checks
- Retrieve BIs and incubate per manufacturer instructions (48–72 hours).
- Observe CIs for color change, confirming sterilant exposure.
- Compare parameters against predefined acceptance criteria.
Step 5: Documentation
- Record date, batch number, cycle ID.
- Document BI and CI locations.
- Log sterilant concentration and exposure time.
- Include incubation results of BIs and any deviations or corrective actions.
Acceptance Criteria
- BIs must show no growth after incubation.
- CIs must indicate complete sterilant contact.
- Cycle parameters must match the validated cycle ranges.
Best Practices
- Place BIs in worst-case areas like corners and under shelves.
- Validate cycles periodically, e.g., every 6–12 months or after system changes.
- Maintain cycle logs for regulatory inspections.
- Use automated reporting where available.
Written by Pharma Microbiology Expert Sivasankar.
💬 About the Author
Siva Sankar is a Pharmaceutical Microbiology Consultant and Auditor with extensive experience in sterility testing, validation, and GMP compliance. He provides consultancy, training, and documentation services for pharmaceutical microbiology and cleanroom practices.
📧 Contact: siva17092@gmail.com
📱 Mobile: 09505626106